In the early‐warning biomarkers panel, the OST4, PKIG and RPL23 genes were identified and used to create a non‐invasive and straightforward nomogram model for accurately predicting the risk of CAD exacerbation. This evidence concerns the gene RPL23 and coronary artery disorder.